1. Long non-coding RNA FEZF1-AS1 promotes rectal cancer progression by competitively binding miR-632 with FAM83A
- Author
-
Xie Rongjun, Liu Chubao, Liu Longfei, Lu Xianzhou, and Tang Guohui
- Subjects
FEZF1-AS1 ,miR-632 ,FAM83A ,rectal cancer ,proliferation ,migration ,invasion ,Biochemistry ,QD415-436 ,Genetics ,QH426-470 - Abstract
The long non-coding RNA (lncRNA) forebrain embryonic zinc finger protein 1 antisense RNA1 (FEZF1-AS1) was recently identified as an oncogenic gene in several types of tumors. The biological function of FEZF1-AS1 in rectal cancer progression, however, remains unknown. In the present study, we discover that FEZF1-AS1 is significantly upregulated in rectal cancer tissues and cells. Knocking down of FEZF1-AS1 suppresses cell proliferation, migration, and invasion in vitro, and tumorigenesis in vivo. Furthermore, FEZF1-AS1 functions as a competing endogenous RNA (ceRNA) for miR-632, resulting in the suppression of family with sequence similarity 83, member A (FAM83A). Overall, our findings reveal that FEZF1-AS1/miR-632/FAM83A axis plays an oncogenic role in rectal cancer progression, suggesting that it may be a novel therapeutic target for rectal cancer.
- Published
- 2022
- Full Text
- View/download PDF